| Dr Bojana Jovanovic, MD | |
|
14500 Hall Rd, Sterling Heights, MI 48313-1229 | |
| (313) 916-2631 | |
| Not Available |
| Full Name | Dr Bojana Jovanovic |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Rheumatology |
| Location | 14500 Hall Rd, Sterling Heights, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962781807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 284175 (New York) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 4301111372 (Michigan) | Primary |
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
Polaris Group announced today that positive results from a randomized Phase 2 trial of ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, for the treatment of malignant pleural mesothelioma were presented at the World Conference on Lung Cancer in Sydney, Australia.
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
Amedica Corporation, a commercial biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and sell novel medical devices, is pleased to announce the release of its second generation silicon nitride transforaminal lumbar (TL) interbody fusion device.
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at the European Respiratory Society International Congress today.
The Allen Institute for Brain Science announced today its twentieth public data release, which includes new data and tools for exploring genes at work in the human brain. In addition to expanding and enhancing the Allen Human Brain Atlas, the Allen Institute launched two new human brain resources: the Ivy Glioblastoma Atlas Project and the NIMH Transcriptional Atlas of Human Brain Development.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bojana Jovanovic, MD 14500 Hall Rd, Sterling Heights, MI 48313-1229 Ph: (313) 916-2631 | Dr Bojana Jovanovic, MD 14500 Hall Rd, Sterling Heights, MI 48313-1229 Ph: (313) 916-2631 |
News Archive
Polaris Group announced today that positive results from a randomized Phase 2 trial of ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, for the treatment of malignant pleural mesothelioma were presented at the World Conference on Lung Cancer in Sydney, Australia.
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
Amedica Corporation, a commercial biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and sell novel medical devices, is pleased to announce the release of its second generation silicon nitride transforaminal lumbar (TL) interbody fusion device.
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at the European Respiratory Society International Congress today.
The Allen Institute for Brain Science announced today its twentieth public data release, which includes new data and tools for exploring genes at work in the human brain. In addition to expanding and enhancing the Allen Human Brain Atlas, the Allen Institute launched two new human brain resources: the Ivy Glioblastoma Atlas Project and the NIMH Transcriptional Atlas of Human Brain Development.
› Verified 2 days ago
Dr. Nagina Aslam, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 13801 15 Mile Rd, Sterling Heights, MI 48312 Phone: 586-757-9707 | |
Yousuf A. Siddiqui, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 14500 Hall Road, Sterling Heights, MI 48313 Phone: 586-247-2940 Fax: 586-247-3733 | |
Jayashree Sekaran, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 3500 Fifteen Mile Road, Sterling Heights, MI 48310 Phone: 586-977-9936 Fax: 586-268-8158 | |
Dr. Stanley B Wolfe, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 37771 Schoenherr Rd, Suite 101, Sterling Heights, MI 48312 Phone: 586-274-2450 Fax: 586-274-2481 | |
Maria Repolski, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: Henry Ford Health System, 14500 Hall Road, Sterling Heights, MI 48313 Phone: 586-247-2940 Fax: 586-247-3733 | |
Dr. Sharon K Geimer, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 44344 Dequindre Rd, Suite 480, Sterling Heights, MI 48314 Phone: 586-323-8935 Fax: 586-323-9058 | |
Dr. Amro Reda Sheta, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2405 E Fourteen Mile Rd, Sterling Heights, MI 48310 Phone: 586-264-1800 Fax: 586-264-1155 |